Kim Jiny 4
4 · Cytosorbents Corp · Filed Aug 26, 2022
Insider Transaction Report
Form 4
Kim Jiny
Director
Transactions
- Purchase
Common Stock
2022-08-25$1.91/sh+1,000$1,910→ 70,300 total
Footnotes (2)
- [F1]The transaction reported on this Form 4 were open market purchases made by the reporting person pursuant to a trading plan adopted by the reporting person that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
- [F2]Includes (a) 69,300 restricted stock units ("RSUs") granted on April 1, 2022 that will be settled into shares of the Issuer's common stock upon vesting upon a "Change In Control" of the Issuer as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan") and (b) 1,000 shares of owned directly reported by the reporting person and reported on this Form 4.